Moving into the mainstream: healthcare professionals’ views of implementing treatment focussed genetic testing in breast cancer care
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Moving into the mainstream: healthcare professionals’ views of implementing treatment focussed genetic testing in breast cancer care
Authors
Keywords
<em class="EmphasisTypeItalic ">BRCA1</em> and <em class="EmphasisTypeItalic ">BRCA2</em> treatment focussed testing, Mainstreaming, Clinician perspectives, Qualitative analysis
Journal
Familial Cancer
Volume -, Issue -, Pages -
Publisher
Springer Nature
Online
2019-01-28
DOI
10.1007/s10689-019-00122-y
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Gaps in Receipt of Clinically Indicated Genetic Counseling After Diagnosis of Breast Cancer
- (2018) Steven J. Katz et al. JOURNAL OF CLINICAL ONCOLOGY
- Mainstreamed genetic testing for women with ovarian cancer: first-year experience
- (2018) Belinda Rahman et al. JOURNAL OF MEDICAL GENETICS
- Carboplatin in BRCA1/2-mutated and triple-negative breast cancer BRCAness subgroups: the TNT Trial
- (2018) Andrew Tutt et al. NATURE MEDICINE
- Mainstreaming cancer genetics: A model integrating germline BRCA testing into routine ovarian cancer clinics
- (2017) Maira Kentwell et al. GYNECOLOGIC ONCOLOGY
- Risks of Breast, Ovarian, and Contralateral Breast Cancer for BRCA1 and BRCA2 Mutation Carriers
- (2017) Karoline B. Kuchenbaecker et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Gaps in Incorporating Germline Genetic Testing Into Treatment Decision-Making for Early-Stage Breast Cancer
- (2017) Allison W. Kurian et al. JOURNAL OF CLINICAL ONCOLOGY
- Baseline clinical predictors of antitumor response to the PARP inhibitor olaparib in germline BRCA1/2 mutated patients with advanced ovarian cancer
- (2017) Saeed Rafii et al. Oncotarget
- Delivering widespread BRCA testing and PARP inhibition to patients with ovarian cancer
- (2016) Angela George et al. Nature Reviews Clinical Oncology
- Understanding of BRCA VUS genetic results by breast cancer specialists
- (2015) B. K. Eccles et al. BMC CANCER
- Treatment Decision Making and Genetic Testing for Breast Cancer
- (2015) Steven J. Katz et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Phase II Study of Gemcitabine, Carboplatin, and Iniparib As Neoadjuvant Therapy for Triple-Negative and BRCA1/2 Mutation–Associated Breast Cancer With Assessment of a Tumor-Based Measure of Genomic Instability: PrECOG 0105
- (2015) Melinda L. Telli et al. JOURNAL OF CLINICAL ONCOLOGY
- Development of cancer genetic services in the UK: A national consultation
- (2015) Ingrid Slade et al. Genome Medicine
- Health professionals’ evaluation of delivering treatment-focused genetic testing to women newly diagnosed with breast cancer
- (2014) Kirsten F. L. Douma et al. Familial Cancer
- Primary-care providers’ perceived barriers to integration of genetics services: a systematic review of the literature
- (2014) Natalie A. Mikat-Stevens et al. GENETICS IN MEDICINE
- A cancer genetics toolkit improves access to genetic services through documentation and use of the family history by primary-care clinicians
- (2013) Maren T. Scheuner et al. GENETICS IN MEDICINE
- Oncology health professionals’ attitudes toward treatment-focused genetic testing for women newly diagnosed with breast cancer
- (2013) Stephanie Burcher et al. Personalized Medicine
- Frequencies of BRCA1 and BRCA2 mutations among 1,342 unselected patients with invasive ovarian cancer
- (2011) Shiyu Zhang et al. GYNECOLOGIC ONCOLOGY
- A toolkit for incorporating genetics into mainstream medical services: Learning from service development pilots in England
- (2010) Catherine L Bennett et al. BMC HEALTH SERVICES RESEARCH
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started